Showing results (311-320 of 474) with videos related to
Sort By:
Pageof 48
The Lancet. Global Health|November 15, 2025
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Guillaume Gingras, et al.Plos One|June 17, 2014
Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionEsther van Kleef, Antonio Gasparrini, Rebecca Guy, et al.Cost Effectiveness and Resource Allocation : C/E|May 14, 2024
An overview of the perspectives used in health economic evaluationsManit Sittimart, Waranya Rattanavipapong, Andrew J Mirelman, et al.BMJ Quality & Safety|June 6, 2018
Addressing the challenges of knowledge co-production in quality improvement: learning from the implementation of the researcher-in-residence modelCecilia Vindrola-Padros, Laura Eyre, Helen Baxter, et al.Vaccine|August 19, 2014
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling studyJean-François Laprise, Mélanie Drolet, Marie-Claude Boily, et al.BMC Medicine|March 3, 2021
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling studyChangfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.The Lancet. Global Health|July 21, 2020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infectionKaja Abbas, Simon R Procter, Kevin van Zandvoort, et al.Pharmacoeconomics - Open|October 20, 2025
An Introduction to Costing and the Types of Costs Used within Health Economic StudiesHugo C Turner, Juan Carlos Rivillas-Garcia, Shankar Prinja, et al.Health Research Policy and Systems|June 26, 2024
A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptakeBenjamin S C Uzochukwu, Chinyere Okeke, Faisal Shuaib, et al.Sexually Transmitted Diseases|February 15, 2011
Prevalence of human papillomavirus antibodies in males and females in EnglandSarika Desai, Ruth Chapman, Mark Jit, et al.Pageof 48